Matches in Nanopublications for { ?s ?p "[Reduced expression of both synaptopodin and GLEPP1 is associated with poor response to steroid therapy in primary focal segmental glomerulosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP145938.RAytLTXrBXP0a3rVdpirkcA2jqAXxdWgeo8htpU_KkPNs130_assertion description "[Reduced expression of both synaptopodin and GLEPP1 is associated with poor response to steroid therapy in primary focal segmental glomerulosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP145938.RAytLTXrBXP0a3rVdpirkcA2jqAXxdWgeo8htpU_KkPNs130_provenance.
- NP145950.RAwJJNMy48caric8XNFkG89qsv1RNAsEYCSNaYSYLhyqM130_assertion description "[Reduced expression of both synaptopodin and GLEPP1 is associated with poor response to steroid therapy in primary focal segmental glomerulosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP145950.RAwJJNMy48caric8XNFkG89qsv1RNAsEYCSNaYSYLhyqM130_provenance.
- assertion description "[Reduced expression of both synaptopodin and GLEPP1 is associated with poor response to steroid therapy in primary focal segmental glomerulosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Reduced expression of both synaptopodin and GLEPP1 is associated with poor response to steroid therapy in primary focal segmental glomerulosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP209078.RAAEVX31O78_FfKiZXck-FNpB6RxfWZ1o8RhQcK3cvqzw130_assertion description "[Reduced expression of both synaptopodin and GLEPP1 is associated with poor response to steroid therapy in primary focal segmental glomerulosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP209078.RAAEVX31O78_FfKiZXck-FNpB6RxfWZ1o8RhQcK3cvqzw130_provenance.
- NP209090.RAGCO7VVKjZlOo4-5dwGt9T4f7f4PKZ0zLAkqt3F2hFIQ130_assertion description "[Reduced expression of both synaptopodin and GLEPP1 is associated with poor response to steroid therapy in primary focal segmental glomerulosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP209090.RAGCO7VVKjZlOo4-5dwGt9T4f7f4PKZ0zLAkqt3F2hFIQ130_provenance.
- NP216275.RA1cyAKlCJKkh0D0SNKWfNcpNdb_nScyPqxILF08sm27M130_assertion description "[Reduced expression of both synaptopodin and GLEPP1 is associated with poor response to steroid therapy in primary focal segmental glomerulosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP216275.RA1cyAKlCJKkh0D0SNKWfNcpNdb_nScyPqxILF08sm27M130_provenance.
- NP216276.RA1bc3_oBROnzvvoz1MOBQYX3FR1p5Cdc2Wf8Ws3yQ-LE130_assertion description "[Reduced expression of both synaptopodin and GLEPP1 is associated with poor response to steroid therapy in primary focal segmental glomerulosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP216276.RA1bc3_oBROnzvvoz1MOBQYX3FR1p5Cdc2Wf8Ws3yQ-LE130_provenance.